IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 55
Titolo Data di pubblicazione Autore(i) File
Switching disease-modifying therapy in multiple sclerosis: escalation therapy has not an advantage on switching among same line drugs 1-gen-2015 Leone, C; Zanghì, A; D'Amico, E; Messina, S; Chisari, C; Caramma, A; Lo Fermo, S; Patti, Francesco; Zappia, Mario
Switching therapy: how and why in a real word setting cohort of persons with multiple sclerosis in Catania 1-gen-2015 Leone, C; Zanghì, A; D'Amico, E; Messina, S; Chisari, C; Caramma, A; Lo Fermo, S; Patti, Francesco; Zappia, Mario
Disease trajectory in secondary progressive multiple sclerosis: a ten years follow-up study 1-gen-2016 D'Amico, E; Zanghi, A; Lo Fermo, S; Zappia, M; Patti, F
Lateral and escalation therapy in relapsing-remitting multiple sclerosis: a comparative study 1-gen-2016 D'Amico, E; Leone, C; Zanghì, A; Lo Fermo, S; Patti, Francesco
Treatment-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: A Comprehensive Review of Current Evidence and Future Needs 1-gen-2016 D'Amico, E; Zanghì, A; Leone, C; Hayrettin, Tumani; Patti, Francesco
Real-World comparison of reasons for changing treatment to dimethyl-fymarate or teriflunomide in non responders patients with relapsing remitting multiple sclerosis: preliminary results of a multicenter prospective study 1-gen-2016 D'Amico, E; Zanghi, A; Callari, G; Lo Fermo, S; Valentino, P; Tiziana, N; Bruno Bossio, R; Cottone, S; Salomone, G; Zappia, Mario; Grimaldi, L; Patti, Francesco
Personalized Therapy in Multiple Sclerosis: state of art and future perspectives 1-gen-2016 D'Amico, E; Zanghì, A; Patti, Francesco
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives 1-gen-2016 D'Amico, E; Patti, Francesco; Zanghì, A; Zappia, Mario
Real-world comparison of safety profile in two groups of relapsing remitting multiple sclerosis on dimethyl-fumarate and teriflunomide therapy: preliminary results of a multicenter, prospective study 1-gen-2016 D'Amico, E; Callari, G; Zanghì, A; Lo Fermo, S; Grimaldi, L; Zappia, Mario; Patti, Francesco
Real-world comparison of Dimethyl-fumarate and teriflunomide in treatment-naive and non responders patients with relapsing remitting multiple sclerosis: preliminary data of a multicenter, prospectie study 1-gen-2016 D'Amico, E; Callari, G; Zanghì, A; Lo Fermo, S; Valentino, P; Tiziana, N; Bruno Bossio, R; Cottone, S; Salomone, G; Zappia, Mario; Grimaldi, L; Patti, Francesco
Can new chemical therapies improve the management of multiple sclerosis in children? 1-gen-2017 D'Amico, E; Zanghì, A; Patti, Francesco
Palliative care in progressive multiple sclerosis 1-gen-2017 D'Amico, E; Zanghì, A; Patti, Francesco; Zappia, Mario
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 1-gen-2018 D’Amico, E.; Patti, F.; Zanghi', Aurora; Lo Fermo, S.; Chisari, C. G.; Zappia, M.
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 1-gen-2018 D'Amico, E; Patti, F; Zanghì, A; Chisari, C G; Lo Fermo, S; Zappia, M
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 1-gen-2018 D'Amico, Emanuele; Zanghì, Aurora; Callari, Graziella; Borriello, Giovanna; Gallo, Antonio; Graziano, Giusi; Valentino, Paola; Buccafusca, Maria; Cottone, Salvatore; Salemi, Giuseppe; Ragonese, Paolo; Bossio, Roberto Bruno; Docimo, Renato; Grimaldi, Luigi Maria Edoardo; Pozzilli, Carlo; Tedeschi, Gioacchino; Zappia, Mario; Patti, Francesco
Monocytic myeloid derived suppressor cells in hematological malignancies 1-gen-2019 Palumbo, ; G. A., Parrinello; N. L., Giallongo; D'Amico, Emanuele; Zanghi', Aurora; Puglisi, ; F., Conticello; C., Chiarenza; A., Tibullo; D., Raimondo; F. D., Romano
Management of dysphagia in multiple sclerosis: current best practice 1-gen-2019 D’Amico, Emanuele; Zanghì, Aurora; Serra, Agostino; Murabito, Paolo; Zappia, Mario; Patti, Francesco; Cocuzza, Salvatore
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 1-gen-2019 D’Amico, E.; Zanghì, A.; Sciandra, M.; Borriello, G.; Callari, G.; Gallo, A.; Salemi, G.; Cottone, S.; Buccafusca, M.; Valentino, P.; Bossio, R. B.; Grimaldi, L. M. E.; Pozzilli, C.; Tedeschi, G.; Zappia, M.; Patti, F.
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 1-gen-2019 D'Amico, Emanuele; Chisari, Clara G.; Arena, Sebastiano; Zanghì, Aurora; Toscano, Simona; Lo Fermo, Salvatore; Maimone, Davide; Castaing, Marine; Sciacca, Salvatore; Zappia, Mario; Patti, Francesco
An update on the safety of treating relapsing-remitting multiple sclerosis 1-gen-2019 Chisari, Clara G; Toscano, Simona; D'Amico, Emanuele; Lo Fermo, Salvatore; Zanghì, Aurora; Arena, Sebastiano; Zappia, Mario; Patti, Francesco
Mostrati risultati da 1 a 20 di 55
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile